Palivizumab, nabava za 2025.- 2027. godinu
Awarded
The competition has ended and a winner has been selected.
- Procedure
- OpenSingle stage
- Agreement
- Framework agreement
- Estimated value
- €7.2M
Brief
Hrvatski zavod za javno zdravstvo sklopio je okvirni sporazum s tvrtkom OKTAL PHARMA d.o.o. za nabavu Palivizumaba za razdoblje od 2025. do 2027. godine, s konačnom vrijednošću od 2.416.230 €. Isporuka se vrši u Gradu Zagrebu. Kriteriji za dodjelu bili su cijena ponude i rok isporuke cijele količine u 2025. godini. Na natječaj su pristigle 3 ponude.
Farmasøytisk engroshandel
Result
- OKTAL PHARMA d.o.o.Winner
- 3Number of bids
- €2,416,230Contract value
Custom Assessment Criteria
Get answers to your bid/no-bid criteria
Set them up once and Cobrief answers them in every tender
Will you bid?
The agent sets up the bid and writes the first draft. Free for 14 days.
Award Criteria
Description
Cijena ponude
Source
No source found in the documents. Check the weight against the tender documents.
Description
Bodovi za rok isporuke cijele količine u 2025. godini dodjeljuju se na slijedeći način: • rok isporuke do 30. rujna 2025: 1 bod • rok isporuke do 15. rujna 2025: 5 bodova
Source
No source found in the documents. Check the weight against the tender documents.
Previous winners
Who are you up against?
The suppliers who have won similar contracts at Hrvatski zavod za javno zdravstvo
From the notice
Palivizumab, nabava za 2025. - 2027. godinuMain features of the procedureOtvoreni postupak
Contact
Nabava HZJZnabava@hzjz.hr- Result · Framework agreementType
- Grad ZagrebLocation
- 33651600Main codeVaccines